IP Verse

Arbutus Biopharma Corporation - App_18039/2025

Explore detailed information on the case number App_18039/2025 involving Arbutus Biopharma Corporation, Genevant Sciences Gmbh and which was filed on 14 Apr, 2025.

Case Details

    Case Number:

    App_18039/2025

    Filing Date:

    14 Apr, 2025

    Proceeding Type:

    Application

    Action/Application:

    Generic Application

    Plaintiffs:

    • Arbutus Biopharma Corporation Represented By Markus Van Gardingen
    • Genevant Sciences Gmbh Represented By Markus Van Gardingen

    Court Division:

    First Instance, Local Division - The Hague

Case Decision

Apr 17, 2025
Document

More cases on Arbutus Biopharma Corporation

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Jul 24, 2025
Case NumberPlaintiffsDefendants
App_18047/2025Genevant Sciences Gmbh, Arbutus Biopharma Corporation -
ACT_10280/2025Arbutus Biopharma Corporation, Genevant Sciences GmbhModernatx, Moderna Italy S.R.L., Moderna Biotech Spain Sl, Moderna Germany Gmbh, Moderna Switzerland Gmbh, Moderna, Moderna Belgium S.R.L., Moderna France Sasu, Moderna Biotech Uk Limited, Moderna Poland Sp. Z.O.O., Moderna Norway As, Moderna Portugal Unipessoal Lda, Moderna Denmark Aps, Moderna Sweden Ab, Moderna Netherlands B.V.
ACT_10284/2025Genevant Sciences Gmbh, Arbutus Biopharma CorporationModerna Poland Sp. Z.O.O., Moderna Sweden Ab, Modernatx, Moderna, Moderna France Sasu, Moderna Germany Gmbh, Moderna Netherlands B.V., Moderna Denmark Aps, Moderna Portugal Unipessoal Lda, Moderna Norway As, Moderna Switzerland Gmbh, Moderna Biotech Uk Limited, Moderna Italy S.R.L., Moderna Belgium S.R.L., Moderna Biotech Spain Sl